We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+14.91%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$242M
AUM Growth
+$46.8M
Cap. Flow
+$26.1M
Cap. Flow %
10.78%
Top 10 Hldgs %
46.63%
Holding
110
New
24
Increased
21
Reduced
24
Closed
20

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$2.39M
2
BABA icon
Alibaba
BABA
+$1.94M
3
GILD icon
Gilead Sciences
GILD
+$1.72M
4
ABBV icon
AbbVie
ABBV
+$1.63M
5
KWEB icon
KraneShares CSI China Internet ETF
KWEB
+$1.48M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.43M
2
IBB icon
iShares Biotechnology ETF
IBB
+$1.35M
3
CSCO icon
Cisco
CSCO
+$1.18M
4
VZ icon
Verizon
VZ
+$1.14M
5
XLNX
Xilinx Inc
XLNX
+$1.04M

Sector Composition

Rank Sector Weight
1 Healthcare 32.28%
2 Technology 13.29%
3 Communication Services 7.57%
4 Financials 4.7%
5 Consumer Discretionary 2.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GDX icon
51
CALL
VanEck Gold Miners ETF
GDX
$22.7B
$901K 0.37%
25,000
+12,500
+100% +$467K
TGT icon
52
Target
TGT
$65.6B
$883K 0.36%
5,000
– –
AAPL icon
53
Apple
AAPL
$4.54T
$862K 0.36%
6,500
-1,500
-19% -$180K
SLV icon
54
iShares Silver Trust
SLV
$28B
$860K 0.35%
35,000
-15,000
-30% -$341K
SPCE icon
55
Virgin Galactic
SPCE
$328M
$831K 0.34%
+1,750
New +$817K
JNJ icon
56
Johnson & Johnson
JNJ
$618B
$787K 0.32%
+5,000
New +$738K
AYX
57
DELISTED
Alteryx Inc
AYX
$731K 0.3%
+6,000
New +$756K
BOX icon
58
Box
BOX
$4.37B
$722K 0.3%
40,000
-10,000
-20% -$174K
CVS icon
59
CALL
CVS Health
CVS
$133B
$683K 0.28%
+10,000
New +$650K
ORCL icon
60
CALL
Oracle
ORCL
$374B
$647K 0.27%
10,000
-5,000
-33% -$298K
GEN icon
61
Gen Digital
GEN
$16.4B
$623K 0.26%
30,000
– –
UCD
62
CALL
DELISTED
PROSHARES ULTRA BLOOMBERG COMMODITY
UCD
$612K 0.25%
+57,500
New +$612K
VIR icon
63
Vir Biotechnology
VIR
$1.46B
$562K 0.23%
21,000
-5,000
-19% -$163K
NXPI icon
64
NXP Semiconductors
NXPI
$57.8B
$557K 0.23%
3,500
– –
MSFT icon
65
Microsoft
MSFT
$3.45T
$556K 0.23%
2,500
– –
NKTR icon
66
Nektar Therapeutics
NKTR
$2.39B
$532K 0.22%
2,087
-33
-2% -$8.53K
GM icon
67
CALL
General Motors
GM
$80.4B
$521K 0.21%
+12,500
New +$486K
FCX icon
68
Freeport-McMoran
FCX
$90B
$520K 0.21%
20,000
-10,000
-33% -$208K
AERI
69
DELISTED
Aerie Pharmaceuticals
AERI
$473K 0.2%
+35,000
New +$423K
BRK.B icon
70
Berkshire Hathaway Class B
BRK.B
$1.1T
$464K 0.19%
2,000
-2,000
-50% -$440K
ARNA
71
DELISTED
Arena Pharmaceuticals Inc
ARNA
$461K 0.19%
6,000
-10,000
-63% -$750K
APTX
72
DELISTED
Aptinyx Inc. Common Stock
APTX
$453K 0.19%
131,000
+39,200
+43% +$137K
VXX icon
73
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$154M
$420K 0.17%
391
+78
+25% +$101K
MTNB icon
74
Matinas BioPharma
MTNB
$1.88M
$415K 0.17%
6,106
-4,930
-45% -$228K
GMAB icon
75
Genmab
GMAB
$17.7B
$407K 0.17%
10,000
-14,500
-59% -$542K
1 2
3
4 5

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, DCF Advisers held 110 positions worth $242M, up 24% from $196M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

DCF Advisers deployed $26.1M of net new capital in Q4 2020, opening 24 new positions and adding to 21 existing holdings. Its largest new stake was Becton Dickinson: 10,250 shares worth $2.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $1.43M trimmed.

  • DCF Advisers's largest Q4 2020 buy was Becton Dickinson: 10,250 shares worth $2.5M.
  • DCF Advisers added most to AbbVie in Q4 2020, an estimated $1.63M increase.
  • DCF Advisers's biggest Q4 2020 reduction was Alphabet (Google) Class C, cutting an estimated $1.43M.
  • DCF Advisers fully exited iShares Biotechnology ETF in Q4 2020, selling an estimated $1.35M.
  • DCF Advisers's ten largest holdings make up 47% of its $242M portfolio in Q4 2020.
  • DCF Advisers opened 24 new positions and closed 20 in Q4 2020.
  • DCF Advisers's portfolio value rose 24% quarter-over-quarter to $242M.

Based on DCF Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.